Series C-stage Healthcare AI investors
Healthcare AI investors writing series c-stage checks. Cross-referenced with portfolio holdings, sub-vertical focus, and check-size range so you can shortlist credible leads for your raise.
Series C funding is secured by highly mature startups aiming to scale aggressively on a global scale, develop entirely new product ecosystems, or execute major corporate acquisitions. Investors participating in Series C rounds—including private equity firms, hedge funds, and investment banks—face lower operational risks and focus primarily on maximizing the company's valuation ahead of a liquidity event.
254
investors match
Within Series C: top healthcare sub-verticals
Lightspeed Venture Partners
VC
T1
AI/ML in Healthcare
Biotech
Lilly Asia Ventures
VC
AI
T3
Biotech
Diagnostics
Longitude Capital
VC
T3
Biotech
Care Delivery / Tech-Enabled Services
Loyal Valley Capital
PE
T3
Biotech
Pharma / Therapeutics
Lundbeckfonden BioCapital
Corporate VC
T3
Biotech
Pharma / Therapeutics
Lux Capital
VC
AI
T1
AI/ML in Healthcare
Biotech
LYFE Capital
VC
T3
Biotech
Digital Health
Madrona Venture Group
VC
T3
AI/ML in Healthcare
Biotech
Martin Ventures
Family Office
T3
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
Matrix Partners China
VC
AI
T1
Biotech
Digital Health
MCI Capital
PE
T3
Health IT / Healthcare Software
Medicxi
VC
T3
Biotech
Pharma / Therapeutics
Medtronic Ventures
Corporate VC
T3
Diagnostics
Digital Health
Menlo Ventures
VC
T3
AI/ML in Healthcare
Biotech
Merck Global Health Innovation Fund
Corporate VC
T3
AI/ML in Healthcare
Diagnostics